Skip to main content
Clinical Trials/NCT03666260
NCT03666260
Completed
Not Applicable

Comparison of the Clinical Effectiveness of the Quadratus Lumborum Block and Femoral Block in the Analgesia of Total Posterior Hip Arthroplasty

CHU de Reims1 site in 1 country179 target enrollmentOctober 8, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Total Hip Replacement Surgery
Sponsor
CHU de Reims
Enrollment
179
Locations
1
Primary Endpoint
morphine consumption
Status
Completed
Last Updated
last year

Overview

Brief Summary

Patients are painful after total hip arthroplasty. These patients have significant co-morbidities. Analgesics cause significant side effects in this population. Locoregional analgesia is therefore an effective means of reducing the consumption of opioids in this surgery.

The "gold standard" of locoregional analgesia after Total Hip Arthroplasty is the femoral block. However, a new technique has recently been described: the Quadratus Lumborum Block.

The comparison of these two techniques is lacking in the literature. The comparison of the Quadratus Lumborum Block to the femoral block in Total Hip arthroplasty is important in the analgesic strategy of patients undergoing this surgery.

Detailed Description

The aim of this study is to compare the clinical efficacy of two regional locoregional analgesia strategies in total hip replacement surgery: the ultrasound-guided Quadratus Lumborum Block and the ultrasound-guided femoral block. This is a double-blind, randomized study in prospective inclusion with a superiority test. Two groups of patients will be compared: a group of patients with a quadratus lumborum block and a group of patients with a femoral block. Management (quadratus lumborum block or femoral block) will be randomized. The randomization will be stratified on the type of anesthesia (spinal anesthesia and general anesthesia). Randomization will be done on the day of surgery to determine the patient's treatment group. The surgical procedure will not be modified by the participation of the patent in the study. Patients who would benefit from total hip replacement surgery in the Reims University Hospital and who agreed to participate in the study were included.

Registry
clinicaltrials.gov
Start Date
October 8, 2018
End Date
July 9, 2021
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients eligible for total hip replacement surgery in Reims University Hospital
  • Patients agreeing to participate in the research and having signed informed consent
  • between 18 yo and 95 yo
  • Patients affiliated to a social security system

Exclusion Criteria

  • Patients with allergy to local anesthetics
  • Patients with neuropathy
  • Patients with an ASA score of 4
  • Patients undergoing revision surgery for total hip arthroplasty
  • Patients receiving anterior hip total hip replacement surgery
  • Patients with a contraindication to the realization of the quadratus lumborum block, femoral block or spinal anesthesia (clinical coagulopathy, infection at the point of puncture ...)
  • Patients refusing the proposed techniques

Outcomes

Primary Outcomes

morphine consumption

Time Frame: 24 hours

Morphine consumption during the 24 hours postoperative

Study Sites (1)

Loading locations...

Similar Trials